法莫替丁(famotidine)是第3代H_2受体阻滞剂,其商品名称Gastcr,是近年来国外报道的新型抗溃疡药。我们于1990年11月～1991年3月对40例消化性溃疡进行临床验证。所用药物由日本山之内制药株式会社提供。一般资料40例均为门诊或因上消化道出血住院病人,多数为近期内有中上腹痛而就诊者,并经纤维胃镜检查证实为活动性胃或十二指肠溃疡者。旦大部 Famotidine is the third generation of H 2 receptor blocker, its trade name Gastcr, is a new antiulcer drug reported in foreign countries in recent years. We in November 1990 ~ March 1991 40 cases of peptic ulcer clinical validation. The medicine used was provided by Yamanouchi Pharmaceutical Co., Ltd. General information 40 cases were outpatients or inpatients with upper gastrointestinal bleeding, most of the recent mid-upper abdominal pain and treatment, and confirmed by gastroscopy for active gastric or duodenal ulcer. Mostly